Showing results (811-820 of 1,154) with videos related to

Sort By:
Pageof 116
Developmental Medicine and Child Neurology|May 26, 2010
Evidence of validity in a new method for measurement of dexterity in children and adolescentsBrigitte Vollmer, Linda Holmström, Lea Forsman, et al.
Cancers|February 15, 2022
Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and ProgressionMaija Puhka, Lisse Thierens, Daniel Nicorici, et al.
Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|January 1, 1991
Magnetocardiographic localisation and modellingJ Nenonen, K Forsman, T Katila, et al.
Drug Design, Development and Therapy|December 10, 2019
Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteersSusanne Prothon, Ulrika Wählby Hamrén, Ulrika Tehler, et al.
Human Molecular Genetics|April 30, 2002
A nonsense mutation in the enamelin gene causes local hypoplastic autosomal dominant amelogenesis imperfecta (AIH2)Carina K Mårdh, Birgitta Bäckman, Gösta Holmgren, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1984
Selenium status in patients receiving home parenteral nutritionC R Fleming, J T McCall, J F O'Brien, et al.
Photosynthesis Research|July 17, 2021
The PsbJ protein is required for photosystem II activity in centers lacking the PsbO and PsbV lumenal subunitsPriscilla Choo, Jack A Forsman, Liangliang Hui, et al.
Experimental Eye Research|April 8, 2014
Pharmacokinetics for topically applied caffeine in the ratMartin Kronschläger, Erik Forsman, Zhaohua Yu, et al.
Work (Reading, Mass.)|January 7, 2017
Health risk appraisals in Swedish occupational health servicesWilhelmus Johannes Andreas Grooten, Mira Müller, Mikael Forsman, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2016
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in ChinaXubin Zheng, Rongrong Zheng, Yi Hu, et al.
Pageof 116